H2020FP7HORIZON
Sanofi Pasteur SA
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 16
- As coordinator
- 2
- EU contribution (CORDIS)
- EUR 1,404,926
- Active
- 2008 to 2025
Projects
16 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| READIResearch in Europe and Diversity Inclusion | HORIZON | 2025 | Associated partner | EUR 0 |
| ENT1DEPENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION | HORIZON | 2024 | Participant | EUR 187,500 |
| PROMISEPreparing for RSV Immunisation and Surveillance in Europe | H2020 | 2021 | Participant | EUR 0 |
| Inno4VacInnovations to accelerate vaccine development and manufacture | H2020 | 2021 | Participant | EUR 0 |
| VITALVaccines and Infectious Diseases in the Ageing PopuLation | H2020 | 2019 | Participant | EUR 0 |
| COMBACTE-CDICombatting Bacterial Resistance in Europe - Clostridium Difficile Infections | H2020 | 2017 | Participant | EUR 0 |
| DRIVEDevelopment of Robust and Innovative Vaccine Effectiveness | H2020 | 2017 | Participant | EUR 0 |
| RESCEUREspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 | H2020 | 2017 | Participant | EUR 0 |
| VAC2VACVaccine lot to Vaccine lot comparison by consistency testing. | H2020 | 2016 | Participant | EUR 0 |
| PERISCOPEPERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 | H2020 | 2016 | Participant | EUR 0 |
| EHVAEuropean HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | H2020 | 2016 | Participant | EUR 50,000 |
| FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection | FP7 | 2015 | Coordinator | Not stated |
| ADVANCEAccelerated Development of Vaccine benefit-risk Collaboration in Europe | FP7 | 2013 | Participant | Not stated |
| BIOVACSAFEBiomarkers For Enhanced Vaccine Safety | FP7 | 2012 | Participant | Not stated |
| STOPENTERICSVaccination against Shigella and ETEC: novel antigens, novel approaches | FP7 | 2010 | Participant | EUR 100,000 |
| EURONEUT-41EUROpean consortium on NEUTralising antibodies using gp41 | FP7 | 2008 | Coordinator | EUR 1,067,426 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.